Original Article

Outcomes of Lobar and Sublobar Resections for Non–Small-Cell Lung Cancer: A Single-Center Experience

Objectives: Lung cancer is the leading cause of cancer-related mortality in the United States. Kentucky has the highest age-adjusted lung cancer rate and has one of the highest death rates from lung cancer in the country. Lobectomy is considered the standard therapy for non–small-cell lung cancer (NSCLC), whereas sublobar resection…

Posted in: lobectomy 4 neoadjuvant therapy 3 nonsmall cell lung cancer 2 outcomes 19

Original Article

Late Stage (III and IV) Non-small Cell Cancer of the Lung: Results of Surgical Resection at Inova Fairfax Hospital

One hundred forty-two patients underwent surgery and related treatment for advanced stage (III, IV) non-small cell cancer of the lung. One hundred seventeen patients underwent up-front surgery, with a hospital mortality rate of 1.7% (2/117). Kaplan-Meier 5-year survival in this group was 31% (± 5). Twenty-five patients underwent neoadjuvant therapy…

Posted in: late stage 2 lung cancer 19 neoadjuvant therapy 3

Review Article

Neoadjuvant Therapy: An Emerging Concept in Oncology

Neoadjuvant therapy, an adjunctive therapy given before the main therapy, has become an integral part of modern multidisciplinary cancer management. Organized by the primary organ involved by cancer, this review summarizes the outcomes of neoadjuvant therapy for common malignant solid tumors, based on large, randomized, controlled trials. In locally advanced…

Posted in: malignancy 5 neoadjuvant therapy 3
SMA Menu